| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |